OyaGen
Pre-clinicalOyaGen is a preclinical drug discovery and development company focused on identification of novel therapeutic indications for infectious diseases and cancer. The Company’s business model is to IND-enable lead compounds for licensing to or partnering with industrial leaders for clinical development.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $5.3M
About
OyaGen is a preclinical drug discovery and development company focused on identification of novel therapeutic indications for infectious diseases and cancer. The Company’s business model is to IND-enable lead compounds for licensing to or partnering with industrial leaders for clinical development.
Biologics
Funding History
2Total raised:$5.3M
Seed$5MFeb 15, 2023
Grant$300KMay 15, 2021